It may be over 50%, easily! The trial wouldn’t be stopped at halfway bc at 190 patients it’d be underpowered. The extra mortality happening now as ICUs are overflowing could have a huge impact on the end result. I think with 87 we’re getting a huge hint that there’s efficacy, we will have to see.